Autori: Andric Zoran G
| Naslov | Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis. (Meeting Abstract) |
| Autori | Trukhin Dmytro Poddubskaya Elena Andric Zoran G Bondarenko Igor N Shevnia Serhii Zaric Bojan Bellala Ravishankar Charoentum Chaiyut Perez Luis Bullo Felicitas Garcia Fernanda |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2021), vol. 39 br. 15, Suppl. S, str. - |
| Projekat | mAbxience Research |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression (Meeting Abstract) |
| Autori | Andric Zoran G Ceric Timur Rancic Milan H Jakopovic Marko Aix S Ponce Ramlau Rodryg Ulanska M Caldwell C Ferrari D Annis A Vukovic V Zaric Bojan |
| Info | ANNALS OF ONCOLOGY, (2021), vol. 32 br. , Suppl. 5, str. S1166-S1166 |
| Projekat | Aileron Therapeutics Inc. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB plus ) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C (Meeting Abstract) |
| Autori | Dziadziuszko R ... Andric Zoran G ... (broj koautora 20) |
| Info | ANNALS OF ONCOLOGY, (2021), vol. 32 br. , Suppl. 5, str. S950-S951 |
| Projekat | F. Hoffmann-La Roche, Ltd.Hoffmann-La Roche |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | A phase I/II dose-escalation and expansion study of ZN-c5, an oral selective estrogen receptor degrader (SERD), as monotherapy and in combination with palbociclib in patients with advanced estrogen receptor (ER)+/HER2-breast cancer (Meeting Abstract) |
| Autori | Abramson V ... Andric Zoran G Milovic-Kovacevic Marijana M Trifunovic Jasna D ... (broj koautora 16) |
| Info | ANNALS OF ONCOLOGY, (2021), vol. 32 br. , Suppl. 5, str. S619-S619 |
| Projekat | Zentalis Pharmaceuticals |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | A Phase 1b/2 Open-Label Study with Randomization in Phase 2 of Imu-131 Her2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients with Her2/Neu Overexpressing Metastatic Or Advanced Adenocarcinoma of the Stomach Or Gastroesophageal Junction. (Meeting Abstract) |
| Autori | Maglakelidze Marina ... Andric Zoran G Nikolic Ivan V ... Radosavljevic Davorin Z Petrovic Zoran ... (broj koautora 17) |
| Info | CANCER RESEARCH, (2021), vol. 81 br. 13, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC) (Article) |
| Autori | Syrigos Konstantinos Abert Istvan Andric Zoran G Bondarenko Igor N Dvorkin Mikhail Galic Kristina Galiulin Rinat Kuchava Vladimer Sriuranpong Virote Trukhin Dmytro Zhavrid Edvard Fu Dongyue Kassalow Laurent M Jones Stephanie Bashir Zahid |
| Info | BIODRUGS, (2021), vol. 35 br. 4, str. 417-428 |
| Projekat | Centus Biotherapeutics |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | HERIZON: Phase 2 part of the IMU-131 HER2/neu vaccine plus chemotherapy study randomized in patients with HER2/NEU overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction (Meeting Abstract) |
| Autori | Maglakelidze Marina ... Andric Zoran G Nikolic Ivan V ... Radosavljevic Davorin Z Petrovic Zeljko M ... (broj koautora 16) |
| Info | ANNALS OF ONCOLOGY, (2021), vol. 32 br. , Suppl. 3, str. S154-S154 |
| Projekat | Imugene Limited |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA) (Article) |
| Autori | Trukhin Dmytro ... Andric Zoran G ... (broj koautora 19) |
| Info | BIODRUGS, (2021), vol. 35 br. 4, str. 429-444 |
| Projekat | mAbxience Research SL |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC) (Meeting Abstract) |
| Autori | Andric Zoran G ... Stojanovic Goran Petrovic Marina D ... (broj koautora 20) |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 4, Suppl. S, str. S753-S754 |
| Projekat | Merck KGaA, Darmstadt, Germany; Merck KGaA; Pfizer |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1-Selected NSCLC (Meeting Abstract) |
| Autori | Herbst Roy S ... Andric Zoran G ... (broj koautora 20) |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 3, Suppl. S, str. S224-S225 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
